Coronavirus company news summary – Thermo Fisher receives EUA extension from FDA – Belkin partners with University of Illinois for FlexVent Gas-Operated Ventilator

13 May 2020 (Last Updated May 13th, 2020 09:51)

Abbott has received Emergency Use Authorization (EUA) from the US Food and Drug Administration (FDA) for its molecular test for Covid-19. The test is designed to be used on Abbott's Alinity molecular laboratory instrument, which the company plans to install in hospitals and health systems in the US to address the rising need for Covid-19 testing.

Thermo Fisher Scientific has announced that the FDA has expanded the EUA for its multiplex real-time PCR test that detects the presence of SARS‑CoV‑2 nucleic acid. Applied Biosystems TaqPath Covid-19 Combo Kit of Thermo Fisher initially received the EUA on 13 March and subsequently was expanded on 20 April. The test provides results in four hours.

Consumer electronics provider Belkin has announced its collaboration with the University of Illinois at Urbana-Champaign's Grainger College of Engineering, for the design of the FlexVent Gas-Operated Ventilator (FlexVent). Belkin will produce the FlexVent pending the review and approval of its EUA application by the FDA. This emergency ventilator is based on the Illinois RapidVent concept, which was published by the University of Illinois in March this year.